Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)
Lp-PLA2 is an enzyme that plays a role in the inflammation of blood vessels and is associated with the formation of atherosclerotic plaques.
Lp-PLA2 is a prognostic biomarker for cardiovascular risk assessment.
Key facts at a glance
- Units
- ng/mL
- Clinical utility
- prognostic
- Result kind
- quantitative
- FDA-cleared
- PLAC Test LP-PLA2, Roche LP-PLA2
Lp-PLA2 is an enzyme that circulates in the blood and is primarily bound to low-density lipoprotein (LDL) particles. It is involved in the inflammatory processes within the arterial walls.
Elevated levels of Lp-PLA2 are associated with an increased risk of cardiovascular events, such as heart attacks and strokes, due to its role in the development of atherosclerosis.
Measuring Lp-PLA2 levels can help clinicians assess the risk of cardiovascular disease and guide treatment strategies, particularly in patients with intermediate risk profiles.
Frequently asked questions
What is the normal range for Lp-PLA2?
How can I lower my Lp-PLA2 levels?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy